Adimab
Kyle Berge, a CPA, has a strong background in finance and accounting. With experience as a Finance Manager at Adimab and Senior Accountant at Gallagher, Flynn & Company, LLP, Kyle has also worked as a Financial Analyst at National Life Group. Kyle obtained their Bachelor's Degree in Accounting and Finance from the University of New Hampshire.
This person is not in any teams
Adimab
1 followers
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.